Synergy CHC (SNYR) risk factors, FY2024 10-K

Synergy CHC's FY2024 10-K, filed Mar 31, 2025, lists 39 risk factors in 3 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
393 groups
Section length
11k wordsItem 1A

Synergy CHC's biggest risks in the FY2024 10-K

  • The company relies heavily on a tiny group of major retail customers accounting for 73% of net revenue.
  • Operations depend completely on third-party contract manufacturers and raw material suppliers.
  • Officers and directors maintain tight control by owning 58% of common stock.

The risks most specific to Synergy CHC

  • Risks Related to Our Business, Strategy and Industry

    We depend on a small number of large retailers for a significant portion of our sales. Our sales growth is dependent upon maintaining our relationships with existing customers, and the loss of any one such customer could materially adversely affect our business and financial performance

    For the year ended December 31, 2024, our top two customers accounted for 73% of our net revenue.

  • Risks Related to Our Business, Strategy and Industry

    If our outside suppliers and manufacturers fail to supply products in sufficient quantities and in a timely fashion, our business could suffer

    Contract manufacturers produce all of our products and acquire raw materials from third-party suppliers.

  • Risks Related to Our Business, Strategy and Industry

    Currently, our officers and directors beneficially own approximately 58% of our outstanding common stock. As a result, they have the ability to determine the outcome on all matters requiring approval of our stockholders, including the election of directors and approval of significant corporate transactions

    Our officers and directors beneficially own approximately 58% of our outstanding common stock.

  • Risks Related to Our Business, Strategy and Industry

    We are highly dependent on our management team, and the loss of our senior executive officers or other key employees could harm our ability to implement our strategies, impair our relationships with customers and adversely affect our business, results of operations and growth prospects

    Our senior executive leadership team includes Jack Ross, Jaime Fickett, and Alfred Baumeler.

  • Legal and Regulatory Risks

    Our products are subject to government regulation, both in the United States and abroad, which could increase our costs significantly and limit or prevent the sale of our products

    The primary regulatory bodies for our products in the United States are the FDA and FTC.

  • Risks Related to Ownership of Our Common Stock

    A significant number of our total outstanding shares are restricted from immediate resale, but may be sold into the market in the near future. This could cause the market price of our common stock to drop significantly, even if our business is doing well

    Officers, directors, and 5% stockholders agreed not to sell shares until April 20, 2025, under an underwriter agreement with Roth Capital Partners, LLC.

All 39 risk factors

Headings as the filing states them, in filing order.

Risks Related to Our Business, Strategy and Industry

  1. 01We operate in a highly competitive industry and our failure to compete effectively could materially and adversely affect our sales and growth prospects
  2. 02Our failure to appropriately respond to changing consumer preferences and demand for new products or product enhancements could significantly harm our relationship with customers and our product sales, as well as our financial condition and operating results
  3. 03We depend on a small number of large retailers for a significant portion of our sales. Our sales growth is dependent upon maintaining our relationships with existing customers, and the loss of any one such customer could materially adversely affect our business and financial performance
  4. 04If our outside suppliers and manufacturers fail to supply products in sufficient quantities and in a timely fashion, our business could suffer
  5. 05A downturn in the economy, could affect consumer purchases of discretionary items such as the health and wellness products that we offer, which could have an adverse effect on our business, financial condition, profitability, and cash flows
  6. 06Adverse or negative publicity could cause our business to suffer
  7. 07We continue to explore new strategic initiatives, but we may not be able to successfully execute on, or realize the expected benefits from, the implementation of our strategic initiatives, and our pursuit of new strategic initiatives may pose significant costs and risks
  8. 08Current and future acquisitions may use significant resources, may be unsuccessful, and could expose us to unforeseen liabilities
  9. 09If we are not able to adequately prevent disclosure of proprietary knowledge, the value of our products could be materially diminished
  10. 10International expansion will subject our business to additional economic and operational risks that could increase our costs and make it difficult to operate profitably
  11. 11We may experience product recalls, withdrawals or seizures, which could materially and adversely affect our business, financial condition and results of operations
  12. 12Increases in the price or shortages of supply of key raw materials could materially and adversely affect our business, financial condition and results of operations
  13. 13We are subject to credit risk
  14. 14Loss of key vendor relationships or failure of a vendor to protect our data or confidential and proprietary information could affect our operations
  15. 15Our e-commerce business is dependent on certain third parties. Changes in business practices or terms by such third parties could have a material adverse effect on our results of operations
  16. 16If we do not successfully develop and maintain a relevant omni-channel experience for our customers, our business and results of operations could be materially and adversely affected
  17. 17Currently, our officers and directors beneficially own approximately 58% of our outstanding common stock. As a result, they have the ability to determine the outcome on all matters requiring approval of our stockholders, including the election of directors and approval of significant corporate transactions
  18. 18We are highly dependent on our management team, and the loss of our senior executive officers or other key employees could harm our ability to implement our strategies, impair our relationships with customers and adversely affect our business, results of operations and growth prospects
  19. 19Cyber incidents or attacks directed at us could result in information theft, data corruption, operational disruption and/or financial loss
  20. 20Our existing indebtedness may adversely affect our ability to obtain additional funds and may increase our vulnerability to economic or business downturns
  21. 21We may need to raise additional capital in the future, and our failure to do so could restrict our operations or adversely affect our ability to operate and continue our business. There is no guarantee that we will successfully raise additional capital on favorable terms or at all and if and when we need it

Legal and Regulatory Risks

  1. 22Our products are subject to government regulation, both in the United States and abroad, which could increase our costs significantly and limit or prevent the sale of our products
  2. 23Any or all of these requirements could have a material adverse effect on us. There can be no assurance that the regulatory environment in which we operate will not change or that such regulatory environment, or any specific action taken against us, will not result in a material adverse effect on us
  3. 24Our failure to comply with regulations could result in substantial monetary penalties and could adversely affect our operating results
  4. 25We may experience Lanham Act claims by competitors, and litigation to prosecute such claims
  5. 26If we fail to protect the integrity and security of customer-related and other confidential information, we could be exposed to litigation, increased costs and reputational damage, and our business, results of operations and financial condition could be materially and adversely affected
  6. 27Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect our financial results

Risks Related to Ownership of Our Common Stock

  1. 28There is a limited trading market for the Company’s common stock; it may be difficult to sell shares
  2. 29The price of our common stock may be volatile, and you may be unable to resell your shares at or above the price paid
  3. 30You may be diluted by future issuances of common stock in connection with our incentive plans, acquisitions or otherwise; future sales of such shares in the public market, or the expectations that such sales may occur, could lower our stock price
  4. 31A significant number of our total outstanding shares are restricted from immediate resale, but may be sold into the market in the near future. This could cause the market price of our common stock to drop significantly, even if our business is doing well
  5. 32We do not anticipate paying any cash dividends on our common stock in the foreseeable future
  6. 33If securities or industry analysts do not publish research or reports about our business, or if they downgrade their recommendations regarding our common stock, its trading price and volume could decline
  7. 34The requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain executive management and qualified board members
  8. 35We may be subject to additional regulatory burdens resulting from our recent public listing
  9. 36The existence of indemnification rights held by our directors, officers and employees may result in substantial expenses
  10. 37Anti-takeover effects of certain provisions of Nevada state law hinder a potential takeover of us
  11. 38Nevada’s control share law may have the effect of discouraging takeovers of the corporation
  12. 39We may experience fluctuations in our tax obligations and effective tax rate, which could materially and adversely affect our results of operations

Other Synergy CHC 10-Ks

  • FY2025 10-K risk factors
    38 risks1 new2 dropped3 reworded

    International sales dropped to 10.1% in 2025 and 11.5% in 2024.

    Filed Apr 01, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.